PUMA BIOTECHNOLOGY, INC.

LOS ANGELES, RI · Founded 2007 · Biotech · Public

Small molecule cancer therapeutics (neratinib and alisertib)

Claim this profile

Follows are private to you and power your alerts

Updated · pumabiotechnology.com

Sector
Biotech
Headquarters
LOS ANGELES, RI
Founded
2007
Latest Form D
$5M, Dec 2011
Total capital
$75M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$75M
2 Form D · last Dec 2011
179 months since last filing
Federal contracts
$47K
5 awards · Veterans Affairs
Rank in Biotech#357 of 4373
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

20112012201320142015201620172018FEDERAL ↑EQUITY ↓Cumulative $75M$8K$8K$16K1st Form D$70M
2011201320152017FEDERAL ↑EQUITY ↓Cumulative $75M$8K$16K1st Form D$70M

Latest events

  • Federal contractVeterans Affairs · Neratinib Bullk Order For Puget Sound$16K
  • Federal contractVeterans Affairs · Neratinib 14MG Nerlynx$8K
  • Federal contractVeterans Affairs · Neratinib Nerlynx 40 Mg 1 Bottle$8K
  • Federal contractVeterans Affairs · Emergency Neratinib For Puget Sound$8K
  • Federal contractVeterans Affairs · Neratinnib Nerlynx 40 Mg 1 Bottle 180 Tablets$8K
  • Private capital raisedForm D · SEC · 2nd filing$5M
  • Private capital raisedForm D · SEC · 1st filing$70M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • Alan H. AuerbachExecutive Officer, DirectorNamed in SEC Form D filings
  • Charles R. EylerExecutive OfficerNamed in SEC Form D filings
  • RICHARD R. PHILLIPS, M.D.Executive OfficerNamed in SEC Form D filings
  • Thomas R. MalleyDirectorNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

  • Oralome IncSimilar federal contract value in Biotech · $50K in contracts
  • AlleviSimilar federal contract value in Biotech · $49K in contracts
  • Ichor Life Sciences, Inc.Similar federal contract value in Biotech · $47K in contracts
  • Miromatrix Medical Inc.Similar federal contract value in Biotech · $46K in contracts
  • BIOVINC, LLCSimilar federal contract value in Biotech · $45K in contracts
  • Vaxxinity, Inc.Similar federal contract value in Biotech · $39K in contracts

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .